{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:31Z","timestamp":1760956111853,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071614945"},{"type":"electronic","value":"9781071614952"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1495-2_3","type":"book-chapter","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T04:02:52Z","timestamp":1622088172000},"page":"27-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u03b1-Synuclein Seeding Assay Using Cultured Cells"],"prefix":"10.1007","author":[{"given":"Jun","family":"Ogata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Shimonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"issue":"9996","key":"3_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"2","key":"3_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"JE Galvin","year":"2001","unstructured":"Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58(2):186\u2013190. https:\/\/doi.org\/10.1001\/archneur.58.2.186","journal-title":"Arch Neurol"},{"issue":"2","key":"3_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"issue":"7","key":"3_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, Castano-Diez D, Schweighauser G, Graff-Meyer A, Goldie KN, Sutterlin R, Huisman E, Ingrassia A, Gier Y, Rozemuller AJM, Wang J, Paepe A, Erny J, Staempfli A, Hoernschemeyer J, Grosseruschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, Van IWFJ, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, Van de Berg WDJ, Lauer ME (2019) Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci 22(7):1099\u20131109. https:\/\/doi.org\/10.1038\/s41593-019-0423-2","journal-title":"Nat Neurosci"},{"issue":"9","key":"3_CR5","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"AL Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier AL, Burtscher J, Maharjan N, Weerens L, Croisier M, Kuttler F, Leleu M, Knott GW, Lashuel HA (2020) The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci U S A 117(9):4971\u20134982. https:\/\/doi.org\/10.1073\/pnas.1913904117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318(1):121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"issue":"11","key":"3_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/NEN.0b013e31818b4126","volume":"67","author":"R Sengoku","year":"2008","unstructured":"Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemaru K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S (2008) Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67(11):1072\u20131083. https:\/\/doi.org\/10.1097\/NEN.0b013e31818b4126","journal-title":"J Neuropathol Exp Neurol"},{"issue":"47","key":"3_CR8","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106(47):20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"45","key":"3_CR9","doi-asserted-by":"publisher","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","volume":"285","author":"T Nonaka","year":"2010","unstructured":"Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M (2010) Seeded aggregation and toxicity of \u03b1-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 285(45):34885\u201334898. https:\/\/doi.org\/10.1074\/jbc.M110.148460","journal-title":"J Biol Chem"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, Bockmann A, Meier BH, Melki R (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575. https:\/\/doi.org\/10.1038\/ncomms3575","journal-title":"Nat Commun"},{"issue":"7706","key":"3_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM (2018) Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557(7706):558\u2013563. https:\/\/doi.org\/10.1038\/s41586-018-0104-4","journal-title":"Nature"},{"issue":"1","key":"3_CR12","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, Ge P, Murray KA, Sheth P, Zhang M, Nair G, Sawaya MR, Shin WS, Boyer DR, Ye S, Eisenberg DS, Zhou ZH, Jiang L (2018) Cryo-EM of full-length alpha-synuclein reveals fibril polymorphs with a common structural kernel. Nat Commun 9(1):3609. https:\/\/doi.org\/10.1038\/s41467-018-05971-2","journal-title":"Nat Commun"},{"issue":"7825","key":"3_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, Matsubara T, Tomita T, Ando T, Hasegawa K, Murayama S, Yoshida M, Hasegawa M, Scheres SHW, Goedert M (2020) Structures of alpha-synuclein filaments from multiple system atrophy. Nature 585(7825):464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6","journal-title":"Nature"},{"issue":"1","key":"3_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-018-0532-2","volume":"6","author":"A Tarutani","year":"2018","unstructured":"Tarutani A, Arai T, Murayama S, Hisanaga SI, Hasegawa M (2018) Potent prion-like behaviors of pathogenic alpha-synuclein and evaluation of inactivation methods. Acta Neuropathol Commun 6(1):29. https:\/\/doi.org\/10.1186\/s40478-018-0532-2","journal-title":"Acta Neuropathol Commun"},{"issue":"39","key":"3_CR15","doi-asserted-by":"publisher","first-page":"14241","DOI":"10.1074\/jbc.RA119.008733","volume":"294","author":"J Gao","year":"2019","unstructured":"Gao J, Perera G, Bhadbhade M, Halliday GM, Dzamko N (2019) Autophagy activation promotes clearance of alpha-synuclein inclusions in fibril-seeded human neural cells. J Biol Chem 294(39):14241\u201314256. https:\/\/doi.org\/10.1074\/jbc.RA119.008733","journal-title":"J Biol Chem"},{"issue":"7","key":"3_CR16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.febslet.2006.02.032","volume":"580","author":"M Masuda","year":"2006","unstructured":"Masuda M, Dohmae N, Nonaka T, Oikawa T, Hisanaga S, Goedert M, Hasegawa M (2006) Cysteine misincorporation in bacterially expressed human alpha-synuclein. FEBS Lett 580(7):1775\u20131779. https:\/\/doi.org\/10.1016\/j.febslet.2006.02.032","journal-title":"FEBS Lett"},{"issue":"8","key":"3_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023939","volume":"6","author":"BR Lee","year":"2011","unstructured":"Lee BR, Kamitani T (2011) Improved immunodetection of endogenous alpha-synuclein. PLoS One 6(8):e23939. https:\/\/doi.org\/10.1371\/journal.pone.0023939","journal-title":"PLoS One"}],"container-title":["Methods in Molecular Biology","Experimental Models of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1495-2_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:34:35Z","timestamp":1662168875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1495-2_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071614945","9781071614952"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1495-2_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"28 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}